NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update
Presented Encouraging Phase 2 Data on NUC-7738 in Combination with Pembrolizumab at the European Society for Medical Oncology (ESMO) Congress ...
Cure Today3 天
Magrolimab-Chemo Combo Improves Responses in Metastatic NSCLC
When the drug binds to CD47, it helps destroy the cancer cells directly. In the study, magrolimab was combined with docetaxel, a type of chemotherapy. The study included 31 patients with metastatic ...
来自MSN5 天
Small Benefit, Persistent Toxic Risk With Adjuvant Anthracycline in Breast Cancer
Adding an anthracycline to adjuvant chemotherapy for TOP2A-normal early breast cancer significantly improved disease-free survival (DFS) but not overall survival (OS) at 10 years, and doubled the risk ...
HealthDay on MSN6 天
Understanding the Different Types of Breast Cancer Treatment
The battle against breast cancer has produced significant triumphs in recent years, with new and tailored treatments now ...